Latest filing published 11 May 2021 for Talaris Therapeutics, Inc., €3.3M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sandip Agarwala: trading record in brief
All filings by Sandip Agarwala on record concern Talaris Therapeutics, Inc., in the capacity of senior executive. Altogether 2 filings, all relating to 11 May 2021.
The open-market record is one-sided, with 1 purchase worth €3.3M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 11 May 2021 with an open-market purchase (€3.3M) in Talaris Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sandip Agarwala
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ▲
Same trade as the filing by Longitude Capital Partners III, LLC, counted once
4M USD31SEC235,000 shares@ US$17.00100.0% of flowCommon StockSEC:0000899243-21-019167:1Canonical exit: 9 Aug 2021 (T+90) - 2,985,775 sharesCommon StockSEC:0000899243-21-019167:0
2 of 1 declaration